Sermorelin vs Tesamorelin
Two peptides on the same pathway, separated mostly by how modern and how regulated each is. A useful factual comparison for anyone logging GH-axis compounds.
Side by side
| Sermorelin | Tesamorelin | |
|---|---|---|
| Class | Peptides | Peptides |
| Form | Injection | Injection |
| Half-life | ≈ 12 minutes | ≈ 30 minutes |
| Storage | — | — |
| Dose units | mcg, mg | mg |
| FDA status | Approved | Approved |
Facts from the Stack compound library. See the full pages: Sermorelin · Tesamorelin.
How they differ
Molecule
Sermorelin is a fragment of GHRH (the first 29 amino acids). Tesamorelin is a stabilized GHRH analog engineered for a longer functional life.
Approval
Tesamorelin has a specific FDA-approved indication; sermorelin's regulatory history is different. Each page states its status — read them rather than assuming.
Cadence
Both are injectable peptides reconstituted from powder, so the calculator, refrigeration and opened-vial dates apply to each.
Tracking
GH-axis peptides reward careful timing logs; record the dose, time and site each administration.
Tracking either one
Whichever you log, the workflow is the same in Stack: add it once, set the schedule, and let the app handle reminders, supply projection and an "in your system" curve from the half-life. Run both? Group them into one protocol you can pause together.
Track your stack in Stack
Free, private, no account. Doses, schedules, supply and trends in one quiet app.
Get the appLast reviewed 2026-06-11